Abstract
Cardiovascular disease is the major cause of global mortality and disability. Abundant evidence indicates that amino acids play a fundamental role in cardiovascular physiology and pathology. Decades of research established the importance of L-arginine in promoting vascular health through the generation of the gas nitric oxide. More recently, L-glutamine, L-tryptophan, and L-cysteine have also been shown to modulate vascular function via the formation of a myriad of metabolites, including a number of gases (ammonia, carbon monoxide, hydrogen sulfide, and sulfur dioxide). These amino acids and their metabolites preserve vascular homeostasis by regulating critical cellular processes including proliferation, migration, differentiation, apoptosis, contractility, and senescence. Furthermore, they exert potent anti-inflammatory and antioxidant effects in the circulation, and block the accumulation of lipids within the arterial wall. They also mitigate known risk factors for cardiovascular disease, including hypertension, hyperlipidemia, obesity, and diabetes. However, in some instances, the metabolism of these amino acids through discrete pathways yields compounds that fosters vascular disease. While supplementation with amino acid monotherapy targeting the deficiency has ameliorated arterial disease in many animal models, this approach has been less successful in the clinic. A more robust approach combining amino acidĀ supplementation with antioxidants, anti-inflammatory agents, and/or specific amino acid enzymatic pathway inhibitors may prove more successful. Alternatively, supplementation with amino acid-derived metabolites rather than the parent molecule may elicit beneficial effects while bypassing potentially harmful pathways of metabolism. Finally, there is an emerging recognition that circulating levels of multiple amino acids are perturbed in vascular disease and that a more holistic approach that targets all these amino acid derangements is required to restore circulatory function in diseased blood vessels.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Addabbo F, Chen Q, Patel DP, Rabadi M, Ratliff B, Zhang F et al (2013) Glutamine supplementation alleviates vasculopathy and corrects metabolic profile in an in vivo model of endothelial cell dysfunction. PLoS One 8:e65458
Allerton TD, Proctor DN, Stephens JM, Dugas TR, Spielman G, Irving BA (2018) L-Citrulline supplementation: impact on cardiometabolic health. Nutrients 10:921
Annavarajula SK, Dakshinamurty KV, Naidu MUR, Reddy CP (2012) The effect of L-arginine on arterial stiffness and oxidative stress in chronic kidney disease. Indian J Nephrol 22:340ā346
Atzler D, Schƶnhoff M, Cordts K, Ortland I, Hoppe J, Hummel FC et al (2016) Oral supplementation with L-homoarginine in young volunteers. Br J Clin Pharmacol 82:1477ā1485
Au Yeung SL, Lin SL, Lam HS, Schooling CM (2016) Effect of L-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine on ischemic heart disease risk: a Mendelian randomization study. Am Heart J 182:54ā61
Barth MC, Ahluwalia N, Anderson TJ, Hardy GJ, Sinha S, Alvarez-Cordona JA et al (2009) Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions. J Biol Chem 284:19189ā19195
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R et al (2017) Heart disease and stroke statistics-2017 update. Circulation 135:e146āe603
Bertero T, Oldham WM, Cottrill KA, Pisano S, Vanderpool RR, Yu Q et al (2016) Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension. J Clin Invest 126:3313ā3335
Blum A, Hathaway L, Mincemoyer R, Schenke WH, Kirby M, Csako G et al (2000) Oral L-arginine in patients with coronary artery disease on medical management. Circulation 101:2160ā2164
Boger RH, Bode-Boger SM, Brandes RP, Phivthong-ngam L, Bohme M, Nafe R et al (2007) Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: comparison with lovastatin. Circulation 96:1282ā1290
Caldwell WR, Rodriguez PC, Toque HA, Narayanan SP, Caldwell RB (2018) Arginase: a multifaceted enzyme important in health and disease. Physiol Rev 98:641ā665
Casas JP, Buatista LE, Humphries SE, Hingorani AD (2004) Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation 109:1359ā1364
Castejon AM, Hoffmann IS, Jimenez E, Cubeddu RJ, Baldonedo RM, Cubeddu LX (2002) Differential blood pressure effects of oral glucose and intravenous L-arginine in healthy lean normotensive and obese hypertensive subjects. J Hum Hypert 16 (S1):S133-S136
Chavez-Tostado M, Carrill-Llamas F, Martinez-Gutierrez PE, Alvarado-Ramirez A, Lopez-Taylor JG, Vasquez-Jiminez JC et al (2017) Oral glutamine reduces myocardial damage after coronary revascularization under cardiopulmonary bypass. A random clinical trial. Nutr Hosp 34:277ā283
Chen J, Kuhlencordt PJ, Astern J, Gyurko R, Huang PL (2001) Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein e/endothelial nitric oxide synthase double knockout mice. Circulation 104:2391ā2394
Cheng S, Rhee EP, Larson MG, Lewis GD, McCabe EL, Shen D et al (2012) Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation 125:2222ā2231
Choe CU, Atzler D, Wild PS, Carter AM, Boger RH, Ojeda F et al (2013) Homoarginine levels are regulated by L-arginine:glycine amidinotransferase and affect stroke outcome: results from human and murine studies. Circulation 128:1451ā1461
Cole JE, Astola N, Cribbs AP, Goddard ME, Park I, Green P et al (2015) Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development. Proc Natl Acad Sci USA 112:13033ā13038
Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME (1992) Antiatherogenic effects of L-arginine in the hypercholestrolemic rabbit. J Clin Invest 90:1168ā1172
Durante W (2001) Regulation of L-arginine transport and metabolism in vascular smooth muscle cells. Cell Biochem Biophys 35:19ā34
Durante W (2011) Protective role of heme oxygenase-1 against inflammation in atherosclerosis. Front Biosci 16:2372ā2388
Durante W (2013) Role of arginase in vessel wall remodeling. Front Immunol 4:111
Durante W, Liao L, Peyton KJ, Schafer AI (1998) Thrombin stimulates vascular smooth muscle cell polyamine synthesis by inducing cationic amino acid transporter and ornithine decarboxylase activity. Circ Res 83:217ā223
Durante W, Liao L, Reyna SV, Peyton KJ, Schafer AI (2000) Physiologic cyclic stretch directs L-arginine transport and metabolism to collagen synthesis in vascular smooth muscle cells. FASEB J 14:1775ā1783
Durante W, Liao L, Reyna SV, Peyton KJ, Schafer AI (2001) Transforming growth factor-Ī²1 stimulates L-arginine transport and metabolism in vascular smooth muscle cells: role in polyamine and collagen synthesis. Circulation 103:1121ā1127
Durante W, Johnson FK, Johnson RA (2006) Role of carbon monoxide in cardiovascular function. J Cell Mol Med 10:672ā686
Durante W, Johnson FK, Johnson RA (2007) Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 34:906ā911
Emdin CA, Khera AV, Klarin D, Natarajan P, Zekavat SM, Nomura A et al (2018) Phenotypic consequences of a genetic predisposition to enhanced nitric oxide signaling. Circulation 137:222ā232
Erez A, Nagamani SC, Shchelochkov OA, Premkumar MH, Campeau PM, Chen Y et al (2011) Requirement of arginosuccinate lyase for systemic nitric oxide production. Nat Med 17:1619ā1626
Ford A, Al-Magableh M, Gaspari TA, Hart JL (2013) Chronic NaHS treatment is vasoprotective in high fat-fed ApoE(ā/ā) mice. Int J Vasc Med 2013:915983
Forstermann U, Sessa WC (2012) Nitric oxide synthase: regulation and function. Eur Heart J 33:72ā80
Ganz T, Wainstein J, Gilad S, Limor R, Boaz M, Stern N (2017) Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus. Diabetes Metab Res Rev 33:e2836
Gao L, Xu Z, Yin Z, Chen K, Wang C, Zhang H (2015) Association of hydrogen sulfide with alterations of monocyte chemokine receptors, CCR2 and CX3CR1 in patients with coronary artery disease. Inflamm Res 64:627ā635
Ge J, Cui H, Xie N, Banerjee S, Guo S, Dubey S et al (2018) Glutaminolysis promotes collagen translation and stability via Ī±-ketoglutarate-mediated mTOR activation and proline hydroxylation. Am J Respir Cell Mol Biol 58:378ā390
Gomez I, Ozen G, Deschildre C, Amgoud Y, Boubaya L, Gorenne I et al (2016) Reverse regulatory pathway (H2S/PGE2/MMP) in human aortic aneurysm and saphenous vein varicosity. PLoS One 11:e0158421
Hamon M, Vallet B, Bauters C, Wernert N, McFadden EP, Lablanche JM et al (1994) Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury. Circulation 90:1357ā1362
Hinshaw DB, Burger JM (1990) Protective effect of glutamine on endothelial cell ATP in oxidant injury. J Surg Res 49:222ā227
Hsu CS, Chou SY, Liang SJ, Chang CY, Yeh SL (2006) Effect of physiological levels of glutamine on ICAM-1 expression in endothelial cells activated by preeclamptic plasma. J Reprod Med 51:193ā198
Huang Y, Tang C, Du J, Jin H (2016) Endogenous sulfur dioxide: a new member of the gasotransmitter family in the cardiovascular system. Oxidative Med Cell Longev 2016:8961951
Huang H, Vandekeere S, Kalucka J, Bierhansl L, Zecchin A, Bruning U et al (2017) Role of glutamine and interlinked asparagine metabolism in vessel formation. EMBO J 36:2334ā2352
Ismailova A, Kuter D, Bohle DS, Butler IS (2018) An overview of the potential therapeutic applications of CO-releasing molecules. Bioinorg Chem Appl 2018:8547364
Ito S, Komatsu K, Tsukamoto K, Sved AF (2000) Excitatory amino acids in the rostral ventrolateral medualla support blood pressure in spontaneously hypertensive rats. Hypertension 35:413ā417
Jain SK, Bull R, Rains JL, Bass PF, Levine SN, Reddy S et al (2010) Low levels of hydrogen sulfide in the blood of diabetic patients and streptozotocin-treated rats causes vascular inflammation? Antioxid Redox Signal 12:1333ā1337
Jin HF, Du SX, Zhao X, Wei HL, Wang YF, Liang YF et al (2008) Effects of endogenous sulfur dioxide on monocrotaline-induced pulmonary hypertension in rats. Acta Pharmacol Sin 29:1157ā1166
Johnson FK, Peyton KJ, Liu XM, Azam MA, Shebib AR, Johnson RA et al (2015) Arginase promotes endothelial dysfunction and hypertension in obese rats. Obesity 23:445ā452
Kamata K, Suguira M, Kojima S, Kasuyu Y (1996) Restoration of endothelium-dependent relaxation in both hypercholesterolemia and diabetes by chronic taurine. Eur J Pharmacol 303:47ā53
Kanagy NL, Szabo C, Papapetropoulos A (2017) Vascular biology of hydrogen sulfide. Am J Physiol Cell Physiol 312:C537āC549
Khogali SE, Pringle SD, Weryk BV, Rennie MJ (2002) Is glutamine beneficial in ischemic heart disease? Nutrition 18:123ā126
Kim B, Li J, Jang C, Arany Z (2017) Glutamine fuels proliferation but not migration of endothelial cells. EMBO J 36:2321ā2333
Korthuis RJ, Durante W (2005) Heme oxygenase-1: a pluripotent sentinel limiting the systemic inflammatory response to extremity ischemia and reperfusion. Crit Care Med 33:2701ā2703
Li H, Meininger CJ, Kelly JR Jr, Morris SM Jr, Wu G (2002) Activities of arginase I and II are limiting for endothelial cell proliferation. Am J Physiol Regul Integr Comp Physiol 282:R64āR69
Li W, Tang C, Jin H, Du J (2011) Regulatory effects of sulfur dioxide on the development of atherosclerotic lesions and vascular hydrogen sulfide in atherosclerotic rats. Atherosclerosis 215:323ā330
Li H, Meininger CJ, Bazer FW, WuĀ G (2016) Intracellular sources of ornithine for polyamine synthesis in endothelial cells. Amino Acids 48:2401ā2410
Li Z, Polhemus DJ, Lefer DJ (2018) Evolution of hydrogen sulfide therapeutics to treat cardiovascular disease. Circ Res 123:590ā600
Libby P (2008) The molecular mechanisms of the thrombotic complications of atherosclerosis. J Intern Med 263:517ā527
Lin Y, Chen Y, Zhu N, Zhao S, Fan J, Liu E (2016) Hydrogen sulfide inhibits the development of atherosclerosis through up-regulating protein S-nitrosylation. Biomed Pharmacother 83:466ā476
Liu Z, Han Y, Li L, Lu H, Meng G, Li X et al (2013) The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(ā/ā) mice. Br J Pharmacol 169:1795ā1809
Liu XM, Peyton KJ, Durante W (2017) Ammonia promotes endothelial cell survival via the heme oxygenase-1-mediated release of carbon monoxide. Free Radic Biol Med 102:37ā46
Liu X, Xu X, Shang R, Chen Y (2018) Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease. Nitric Oxide 78:113ā120
Lomivorotov VV, Efremov SM, Shmirev VA, Ponomarev DN, Lomivorotov VN, Karaskov AM (2011) Glutamine is cardioprotective in patients with ischemic heart disease following cardiopulmonary bypass. Heart Surg Forum 14:E384āE388
Ma W, Heianza Y, Huang T, Wang T, Sun D, Zheng Y et al (2018) Dietary glutamine, glutamate, and mortality: two large prospective studies in US men and women. Int J Epidemiol 47:311ā320
Mani S, Li H, Untereiner A, Wu L, Yang G, Austin RC, Dickhout JG et al (2013) Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis. Circulation 127:2523ā2534
Marz W, Meinitzer A, Drechsler C, Pilz S, Krane V, Kleber ME et al (2010) Homoarginine, cardiovascular risk, and mortality. Circulation 122:967ā975
McNamara DB, Bedi B, Aurora H, Tena L, Ignarro LJ, Kadowitz PJ, Akers DL (1993) L-arginine inhibits balloon catheter-induced intimal hyperplasia. Biochem Biophys Res Commun 193:291ā296
McNeal CJ, Meininger CJ, Wilborn CD, Tekwe CD, Wu G (2018) Safety of dietary supplementation with arginine in adult humans. Amino Acids 50:1215ā1229
Meng G, Zhao S, Xie L, Han Y, Ji Y (2018) Protein S-sulfhydration by hydrogen sulfide in cardiovascular system. Br J Pharmacol 175:1146ā1156
Metghalchi S, Ponnuswamy P, Simon T, Haddad Y, Laurans L, Clement M et al (2015) Indoleamine 2,3-dioxygenase fine-tunes immune homeostasis in atherosclerosis and colitis through repression of interleukin-10 production. Cell Metab 22:460ā471
Metghalchi S, Vandestienne M, Haddad Y, Esposito B, Dairou J, Tedgui A et al (2018) Indoleamine 2,3-dioxygenase knockout limits angiotensin II-induced aneurysm in low density lipoprotein receptor-deficient mice fed with high fat diet. PLoS One 13:e0193737
Ming XF, Rajapakse AG, Yepuri G, Xiong Y, Carvas JM, Reffieux J et al (2012) Arginase II promotes macrophage inflammatory responses through mitochondrial reactive oxygen species, contributing to insulin resistance and atherogenesis. J Am Heart Assoc 1:e000992
Morita M, Hayashi T, Ochiai M, Maeda M, Yamaguchi T, Ina K et al (2014) Oral supplementation with combination of L-citrulline and L-arginine rapidly increases plasma L-arginine concentration and enhances NO bioavailability. Biochem Biophys Res Commun 454:53ā57
Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V et al (2005) Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 294:81ā90
Murakami S, Kondo Y, Sakurai T, Kitajima H, Nagate T (2002) Taurine suppresses development of atherosclerosis in Watanabe heritable syndrome hyperlipidemic (WHHL) rabbits. Atherosclerosis 163:79ā87
Murakami S, Sakurai T, Toda Y, Sakono M, Fukuda N (2010) Prevention of neointima formation by taurine ingestion after carotid balloon injury. Vasc Pharmacol 53:177ā184
Murphy C, Newsholme P (1998) Importance of glutamine metabolism in murine macrophages and human monocytes to L-arginine biosynthesis and rates of nitrite or urea production. Clin Sci 95:397ā407
Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF et al (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9:311ā326
Niinisalo P, Raitala M, Pertovaara M, Oja SS, Lehtimaki T, Kahonen M et al (2008) Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: the health 2000 study. Scand J Clin Lab Invest 68:767ā770
Niinisalo P, Oksala N, Levula M, Pelto-Huikko M, Jarvinen O, Salenius JP et al (2010) Activation of indoleamine 2,3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere vascular study. Ann Med 42:55ā63
Ochiai M, Hayashi T, Morita M, Ina K, Maeda M, Watanabe F et al (2012) Short-term effects of L-citrulline supplementation on arterial stiffness in middle-aged men. Int J Cardiol 155:257ā261
Okazaki J, Komori K, Kawasaki K, Eguchi D, Ishida M, Sugimachi K (1997) L-arginine inhibits smooth muscle cell proliferation of vein graft intimal thickness in hypercholestrolemic rabbits. Cardiovasc Res 36:429ā436
Pedersen ER, Tuseth N, Eussen SJ, Ueland PM, Strand E, Svingen GF et al (2015) Association of plasma kynurenines with risk of myocardial infarction in patients with stable angina. Arterioscler Thromb Vasc Biol 35:455ā462
Pernow J, Jung C (2013) Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? Cardiovasc Res 98:334ā343
Pertovaara M, Raitala A, Juonola M, Lehtimaki T, Huhtala H, Oja SS et al (2007) Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study. Clin Exp Immunol 148:106ā111
Peyton KJ, Liu XM, Shebib AR, Johnson FK, Johnson RA, Durante W (2018a) Arginase inhibition prevents the development of hypertension and improves insulin resistance in obese rats. Amino Acids 50:747ā754
Peyton KJ, Liu XM, Yu Y, Yates B, Behnammanesh G, Durante W (2018b) Glutaminase-1 stimulates the proliferation, migration, and survival of human endothelial cells. Biochem Pharmacol 156:204ā214
Pieper GM, Peltier BA (1995) Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium. J Cardiovasc Pharmacol 25:397ā403
Pilz S, Meinitzer A, Tomaschitz A, Drechsler C, Ritz E, Krane V et al (2011) Low homoarginine concentration is a novel risk factor for heart disease. Heart 97:1222ā1227
Polyzos KA, Ovchinnikova O, Berg M, Baumgartner R, Agardh H, Pirault J et al (2015) Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoeā/ā mice. Cardiovasc Res 106:295ā302
Rodriques-Krause J, Krause M, da Rocha IMG, Umpierre D, Fayh APT (2019) Association of L-arginine supplementation with markers of endothelial dysfunction in patients with cardiovascular or metabolic disorders: a systemic review and meta-analysis. Nutrients 11:15
Romero JR, Suzuka SM, Nagel RL, Fabry ME (2002) Arginine supplementation of sickle transgenic mice reduces blood cell density and Gardos channel activity. Blood 99:1103ā1108
Ryoo S, Gupta G, Benjo A, Lim HK, Camara A, Sikkha G et al (2008) Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ Res 102:923ā932
Scalera F, Closs EI, Flick E, Martens-Lobenhoffer J, Boissel JP, Lendeckel U et al (2009) Paradoxical effect of L-arginine: acceleration of endothelial cell senescence. Biochem Biophys Res Commun 386:650ā655
Schulman SP, Becker LC, Kass DA, Champion HC, Terrin ML, Forman S et al (2006) L-arginine therapy in acute myocardial infarction: the Vascular Interaction with Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA 295:58ā64
Schwedhelm E, Maas R, Freese R, Jung D, Lukas Z, Jumbrecina A et al (2008) Pharmacokinetic and pharmacodynamics properties of oral L-citrulline and L-arginine: impact of nitric oxide metabolism. Br J Clin Pharmacol 65:51ā59
Sessa WC, Hecker M, Mitchell JA, Vane JR (1990) The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor. Proc Natl Acad Sci USA 87:8607ā8611
Sufit A, Weitzel LB, Hamiel C, Queensland K, Dauber I, Rooyackers O et al (2012) Pharmacologically dosed oral glutamine reduces myocardial injury in patients undergoing cardiac surgery: a randomized pilot feasibility trial. Enteral Nutr 36:556ā561
Sun Y, Tian Y, Prabha M, Liu D, Chen S, Zhang R et al (2010) Effects of sulfur dioxide on hypoxic pulmonary vascular structural remodeling. Lab Invest 90:68ā82
Tabas I, Garcia-Cardena G, Owens GK (2015) Recent insight into the cellular biology of atherosclerosis. J Cell Biol 209:13ā22
Tang WHW, Wang Z, Cho L, Brennan DM, Hazen SL (2009) Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk. J Am Coll Cardiol 53:2061ā2067
Teupser D, Burkhardt R, Wilfert W, Haffner I, Nebandahl K, Thiery J (2006) Identification of macrophage arginase I as a new candidate gene of atherosclerosis resistance. Arterioscl Thromb Vasc Biol 26:365ā371
Ulrich-Merzenich G, Zeitler H, Vetter H, Bhonde RR (2007) Protective effects of taurine on endothelial cells impaired by high glucose and oxidized low density lipoproteins. Eur J Nutr 46:431ā438
Unterluggauer H, Mazurek B, Lener E, Hutter E, Eigenbrodt W, Zwersche W et al (2008) Premature senescence of human endothelial cells induced by inhibition of glutaminase. Biogerentology 9:247ā259
Vaisman BL, Andrews KL, Khong SML, Wood KC, Moore XL, Fu Y et al (2012) Selective endothelial overexpression of arginase II induces endothelial dysfunction and hypertension and enhances atherosclerosis in mice. PLoS One 7:e39487
Wang Y, Liu H, McKenzie G, Witting PK, Stasch JP, Hahn M et al (2010) Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat Med 16:279ā285
Wang XP, Chen YG, Qin WD, Zhang W, Wei SJ, Wang J et al (2011a) Arginase I attenuates inflammatory cytokine secretion induced by lipopolysaccharide in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 31:1853ā1860
Wang XB, Huang XM, Ochs T, Li XY, Jin HF, Tang CS et al (2011b) Effect of sulfur dioxide preconditioning on rat myocardial ischemia/reperfusion injury by inducing endoplasmic reticulum stress. Basic Res Cardiol 106:865ā878
Wang Q, Zhang M, Ding Y, Wang Q, Zhang W, Song P et al (2014) Activation of NAD(P)H oxidase by tryptophan-derived 3-hydroxykynurenine accelerates endothelial apoptosis and dysfunction in vivo. Circ Res 114:480ā492
Wang ZJ, Wu J, Guo W, Zhu YZ (2017) Atherosclerosis and the hydrogen sulfide signaling pathway: therapeutic approaches to disease prevention. Cell Physiol Biochem 42:859ā875
Wilson AM, Harada R, Nair N, Balasubramanian N, Cooke JP (2007) L-arginine supplementation in peripheral artery disease: no benefit and possible harm. Circulation 116:188ā195
Wirleitner B, Rudzite V, Neurauter G, Murr C, Kalnins U, Erglis A et al (2003) Immune activation and degradation of tryptophan in coronary heart disease. Eur J Clin Invest 33:550ā554
Wu G, Meininger CJ (2000) Arginine nutrition and cardiovascular function. J Nutr 130:2626ā2629
Wu G, Morris SM Jr (1988) Arginine metabolism: nitric oxide and beyond. Biochem J 336:1ā17
Wu G, Haynes TE, Li H, Yan W, Meininger CJ (2001) Glutamine metabolism to glucosamine is necessary for glutamine inhibition of endothelial nitric oxide synthesis. Biochem J 353:245ā252
Wu G, Bazer FW, Davis TA, Kim SW, Li P, Rhoads JM et al (2009) Arginine metabolism and nutrition in growth, health, and disease. Amino Acids 37:153ā168
Wu D, Wang J, Li H, Xue M, Ji A, Li Y (2015) Role of hydrogen sulfide in ischemia-reperfusion injury. Oxidative Med Cell Longev 2015:186908
Wu Z, Hou Y, Hu S, Bazer FW, Meininger CJ, McNeal CJ et al (2016) Catabolism and safety of supplemental L-arginine in animals. Amino Acids 48:1541ā1552
Wurtz P, Makinen VP, Soininen P, Kangas AJ, Turkiainen T, Kettunen J et al (2012) Metabolic signatures of insulin resistance in 7,098 young adults. Diabetes 61:1372ā1380
Xi P, Jiang Z, Zheng C, Lin Y, Wu G (2011) Regulation of protein metabolism by glutamine: implications for nutrition and health. Front Biosci 16:578ā597
Xiao Y, Christou H, Liu L, Visner G, Mitsialis SA, Kouremabana S et al (2013) Endothelial indoleamine 2,3-dioxygenase protects against development of pulmonary hypertension. Am J Respir Crit Care Med 188:482ā491
Xiong Y, Yu Y, Montani JP, Yang Z, Ming XF (2013) Arginase II induces vascular smooth muscle cell senescence and apoptosis through p66Shc and p53 independently of its L-arginine ureahydrolase activity: implications for atherosclerotic plaque vulnerability. J Am Heart Assoc 2:e000096
Yamori Y, Liu L, Ikeda K, Miura A, Mizushima S, Miki T et al (2001) Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study. Hypertens Res 24:453ā457
Yang Y, Wu ZL, Jia SC, Dahanayaka S, Feng S, Meininger CJ, McNeal CJ, Wu G (2015) Safety of long-term dietary supplementation with L-arginine in rats. Amino Acids 47:1907ā1920
Yin J, Ren W, Yang G, Duan J, Huang X, Fang R et al (2016) L-cysteine metabolism and its nutritional implications. Mol Nutr Food Res 60:134ā146
Yun TJ, Lee JS, Machmach K, Shim D, Choi J, Wi YJ et al (2016) Indoleamine 2,3-dioxygenase-expressing aortic plasmacytoid dendritic cells protect against atherosclerosis by induction of regulatory T cells. Cell Metab 23:852ā866
Zhang L, Ovchinnikova O, Jonsson A, Lundberg AM, Berg M, Hansson GK et al (2012a) The tryptophan metabolite 3-hydroxy-anthranilic acid lowers plasma lipids and decreases atherosclerosis in hypercholesterolemic mice. Eur Heart J 33:2025ā2034
Zhang H, Guo C, Wu D, Zhang A, Gu T, Wang L et al (2012b) Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression. PLoS One 7:e41147
Zheng Y, Hu FB, Ruiz-Canela M, Clish CB, Dennis C, Salas-Salvado J et al (2016) Metabolites of glutamate metabolism are associated with incident cardiovascular events in the PREDIMED PREvencion con DIeta MEDiterranea (PREDIMED) trial. J Am Heart Assoc 5:e003755
Zuidema MY, Peyton KJ, Fay WP, Durante W, Korthuis RJ (2011) Antecedent hydrogen sulfide elicits an anti-inflammatory phenotype in postischemic murine small intestine: role of heme oxygenase-1. Am J Physiol Heart Circ Physiol 301:H888āH894
Acknowledgements
This work was supported by American Heart Association grant #17IRG33370074 and American Diabetes Association grant #1-17-IBS-290.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Durante, W. (2020). Amino Acids in Circulatory Function and Health. In: Wu, G. (eds) Amino Acids in Nutrition and Health. Advances in Experimental Medicine and Biology, vol 1265. Springer, Cham. https://doi.org/10.1007/978-3-030-45328-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-45328-2_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-45327-5
Online ISBN: 978-3-030-45328-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)